文献速递冠心病

药物涂层球囊治疗冠状动脉疾病综述

Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review.
PubMed 文献 · JAMA Cardiol · 2025-01-01

该综述总结药物涂层球囊(DCB)的技术原理、全球应用现状、相关适应证及关键操作要点。DCB通过无永久异物植入的均匀抗增殖药物释放,在支架内再狭窄、小血管病、长病变等场景显现优势,高出血风险、糖尿病及急性冠脉综合征患者也可能获益。

要点

  • DCB适用于支架内再狭窄、小血管病、长病变及分叉病变简化等场景
  • 高出血风险、糖尿病和急性冠脉综合征患者可能从DCB血管成形术中获益
  • DCB仅近期获美国FDA批准用于冠状动脉支架内再狭窄治疗

核心结论

  • DCB血管成形术已成为支架内再狭窄及新发冠状动脉疾病PCI中DES植入的替代选择。

研究设计与样本

  • 综述文章,总结DCB技术、全球使用情况、相关适应证及关键操作要点。

主要发现

  • DCB通过无永久异物植入的均匀抗增殖药物释放,有利于血管愈合、保留血管解剖与功能并实现正向血管重塑。
  • DCB对支架内再狭窄、小血管病、长病变、分叉病变简化及慢性完全闭塞再通后弥漫远端病变具有吸引力。
  • 高出血风险、糖尿病和急性冠脉综合征患者可能从DCB血管成形术中获益。
  • DCB在多个国家商业应用已超过十年,但近期才获美国FDA批准用于冠状动脉支架内再狭窄。

临床怎么用

  • 在支架内再狭窄、小血管病、长病变及分叉病变等场景可考虑DCB血管成形术。
  • 高出血风险、糖尿病及急性冠脉综合征患者可评估DCB作为DES替代方案的可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Drug-coated balloon (DCB) angioplasty has emerged as an alternative to drug-eluting stent (DES) implantation for percutaneous coronary intervention (PCI) in patients with coronary in-stent restenosis (ISR) as well as de novo coronary artery disease. OBSERVATIONS: DCBs are balloons coated with antiproliferative agents and excipients, whose aim is to foster favorable vessel healing after appropriate lesion preparation. By providing homogeneous antiproliferative drug delivery in the absence of permanent foreign body implantation, DCBs offer multiple advantages over DES, including preservation of vessel anatomy and function and positive vessel remodeling. As such, DCBs have become appealing for treatment of ISR, small-vessel disease, long lesions, simplification of bifurcation procedures, and treatment of diffuse distal disease after recanalization of chronic total occlusions. In addition, patients with high bleeding risk, diabetes, and acute coronary syndrome might also stand to benefit from DCB angioplasty. CONCLUSIONS AND RELEVANCE: Although commercially available in numerous countries now for more than a decade, DCB only recently obtained US Food and Drug Administration approval for the treatment of coronary ISR. Moreover, preliminary results from newer generation devices tested in different clinical scenarios have raised the interest of the international community. Accordingly, an up-to-date review is timely particularly with the anticipated wave of research on the matter. Herein, this review encompasses DCB technologies, their worldwide usage, details on relevant indications, and key procedural aspects of DCB angioplasty.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Camaj, Leone, Colombo, et al. Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review. JAMA Cardiol. 2025. PMID: 39714903. doi:10.1001/jamacardio.2024.4244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。